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Polymicrobial sepsis is characterized by an early, hyperdynamic phase followed by a late hypodynamic phase. Adrenomedullin (AM), a
vasodilatory peptide, inhibits this transition from the early phase to the late phase. Adrenomedullin binding protein-1 (AMBP-1) enhances AM-
mediated activities. The decrease of AMBP-1 levels in late sepsis reduces the vascular response to AM and produces the hypodynamic phase.
Studies have indicated that the administration of LPS downregulates AMBP-1 production in the liver. Since hepatocytes are the primary source of
AMBP-1 biosynthesis in the liver, we employed a co-culture strategy using hepatocyte and Kupffer cells to determine whether LPS directly or by
increasing pro-inflammatory cytokines from Kupffer cells downregulates AMBP-1 production. Hepatocytes and Kupffer cells isolated from rats
were co-cultured and treated with LPS for 24 h. LPS significantly attenuated AMBP-1 protein expression in a dose-dependent manner. Since
AMBP-1 is basically a secretory protein, cell supernatants from co-culture cells treated with LPS were examined for AMBP-1 protein levels. LPS
treatment caused a dose related decrease in AMBP-1 protein secretion. Similarly, LPS treatment produced a significant decrease in AMBP-1
protein expression in hepatocytes and Kupffer cells cultured using transwell inserts. LPS had no direct effect on AMBP-1 levels in cultured
hepatocytes or Kupffer cells alone. To confirm that the observed effects in co-culture were due to the cytokines released from Kupffer cells,
hepatocytes were treated with IL-1β or TNF-α for 24 h and AMBP-1 expression was examined. The results indicated that both cytokines
significantly inhibited AMBP-1 protein levels. Thus, pro-inflammatory cytokines released from Kupffer cells are responsible for downregulation
of AMBP-1.
© 2007 Elsevier B.V. All rights reserved.Keywords: Adrenomedullin binding protein-1; LPS; Sepsis; TNF-α; IL-1β1. Introduction
Sepsis, septic shock and the ensuing multiple organ failure
continue to be the most common cause of mortality in surgical
intensive care units [1–3]. Enormous efforts have been devoted
to the understanding of sepsis and septic shock to develop new
therapeutic agents which can either reduce or prevent this ever
increasing problem in surgical critical care. Many investigators
have directed their focus to animal models to understand the
physiological consequences of sepsis and septic shock. Cecal⁎ Corresponding author. Division of Surgical Research, The Feinstein Institute
for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
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doi:10.1016/j.bbadis.2007.03.010ligation and puncture (CLP) in rodents has been developed as a
suitable animal model for sepsis since it can produces
pathophysiology (i.e. appendicitis and peritonitis) similar to
that of patients undergoing sepsis [4]. The cardiovascular
response to polymicrobial sepsis induced by CLP is character-
ized by an early, hyperdynamic phase followed by a late,
hypodynamic phase [5]. In addition to the decrease in
hemodynamic parameters, pro-inflammatory cytokines play a
pertinent role in the initiation and progression of sepsis. Among
those, TNF-α, IL-1β and IL-6 became important mediators
during sepsis [6–8]. Recent studies have indicated that
adrenomedullin (AM), a novel vasodilatory peptide, plays an
important role in initiating the hyperdynamic response during
the early phase of polymicrobial sepsis [9–11]. The reduced
vascular responsiveness to AM appears to be responsible for the
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late sepsis [12]. Adrenomedullin binding protein-1 (AMBP-1),
a specific AM binding protein shown to be identical to
complement factor H, augments AM mediated activities [13–
15]. The administration of AM in combination with AMBP-1
(AM/AMBP-1) prevented the decrease in systemic and regional
hemodynamic parameters and prevented the transition from a
hyperdynamic phase to the hypodynamic phase [16].
The liver is a major source of AMBP-1 [17,18] and our
previous studies indicated that both gene and protein expression
of AMBP-1 are markedly reduced in hepatic tissues during the
late phase of sepsis and endotoxemia [19]. However, it is
unclear whether LPS directly or by increasing pro-inflammatory
cytokines downregulates AMBP-1 in sepsis. To answer this
question, a co-culture strategy of hepatocytes and Kupffer cells
were employed in the current study. Hepatocytes and Kupffer
cells were isolated individually, co-cultured or cultured in
transwell inserts and AMBP-1 protein expression was exam-
ined. The effect of pro-inflammatory cytokines, TNF-α and IL-
1β, on AMBP-1 protein expression in hepatocytes was also
analyzed.
2. Materials and methods
2.1. Cell culture
Hepatocytes and Kupffer cells were isolated separately from 6- to 8-week-
old normal Sprague–Dawley rats by collagenase perfusion of the liver
followed by Percoll gradient centrifugation as described previously by us
[20,21]. Hepatocytes were plated at a density of 1×106 cells/well in 6 well
culture plates with Williams medium E containing 10% heat inactivated fetal
bovine serum (FBS), and incubated for 4 h at 37 °C in 5% CO2 . Kupffer cells
were plated at a similar density in 6 well culture plates with DMEM containing
10% FBS and incubated overnight at 37 °C. All media were supplemented with
10 mM HEPES, pH 7.4, 2 mM L-glutamine, 100 units/ml penicillin and
100 μg/ml streptomycin. For co-culture experiments, Kupffer cells were
isolated, plated at 0.5×106 cells/well in 6 well culture plates and incubated
overnight in DMEM and washed twice with phosphate buffered saline (PBS)
and once with Williams medium E. Hepatocytes were plated at a similar
density and plated in direct contact with the attached Kupffer cells in Williams
medium E and incubated at 37 °C. For experiments using transwell inserts,
Kupffer cells were isolated, plated at 1×106 cells/well in 12 well culture plates
and incubated overnight in DMEM and washed twice with PBS and once with
Williams medium E and incubated at 37 °C. Hepatocytes were plated at a
similar density in transwell inserts containing 0.4 μm pore size membrane and
incubated at 37 °C.
2.2. Treatment with LPS or cytokines
After 4 h in co-culture or culture in transwell inserts LPS (1.0–100 ng/ml)
were added and the cells were incubated at 37 °C for 24 h. In experiments with
hepatocytes alone, 4 h after plating, cells were treated with LPS, IL-1β or TNF-α
(1.0, 10 ng/ml) and incubated for 24 h. In experiments with Kupffer cells alone,
cells were plated overnight, washed and treated with LPS.
2.3. Western blotting of AMBP-1 and β-actin
Following treatment, cells were washed in PBS and lysed in 50 mM HEPES
pH 7.5, 250 mM sucrose, 2 mM EDTA, 1.0% Triton-X-100 and a mixture of
protease inhibitors. Cell lysates were prepared by sonication and centrifugation
at 5000×g at 4 °C for 5 min. The resulting cell lysates (25 μg) were
electrophoresed on NuPAGE 3–8% Tris-Acetate gels under non-reducing
conditions and transferred to 0.45 μM nitrocellulose membrane (In Vitrogen,Carlsbad, CA). The membranes were blocked in TBS-T (10 mM Tris–HCl,
150 mM NaCl, 0.1% Tween-20) containing 5% non-fat milk for 1 h at room
temperature. Blots were incubated overnight at 4 °C with 1:5000 dilution of goat
anti-human complement factor H serum (Quidel, San Diego, CA), reacted with
1:10,000 dilution of HRP labeled anti-goat IgG for 1 h at room temperature and
detected with chemiluminescence (ECL; Amersham Biosciences, Inc.). The
same blot was stripped and reprobed with anti-β-actin antibody. Since the
Western blot on AMBP-1 was electrophoresed under non-reducing conditions,
as reported by other authors [15] the antibody to β-actin did not recognize the
protein on the same blot. Therefore, duplicate aliquots of cell lysates (25 μg)
were fractionated on NuPAGE 4–12% Bis-Tris gels under reducing conditions
and transferred to nitrocellulose membrane and Western blotted using anti-β-
actin antibody (Sigma-Aldrich, St. Louis, MO). All membranes were exposed to
X-ray film and the band densities were quantitated using the Bio-Rad image
system (Hercules, CA). The data are represented as the ratio between AMBP-1
and actin protein expression.
The cell supernatants from control, 10 and 100 ng/ml LPS treated samples
were concentrated ten fold using Centricon-50 (Millipore Corp, Bedford, MA)
and an aliquot (2 μl) from each sample was run on SDS-PAGE under non-
reducing conditions and Western blotted using anti-AMBP-1 antibody as
described above.
2.4. Statistical analysis
All data are expressed as mean±SE and analyzed by one-way analysis of
variance (ANOVA) and Student–Newman–Keuls method. The differences in
values were considered significant if Pb0.05.
3. Results
3.1. LPS treatment in co-culture of hepatocytes and Kupffer
cells downregulated AMBP-1 protein expression
We have previously shown that the administration of LPS to
normal Sprague–Dawley rats downregulates AMBP-1 produc-
tion in the liver [19]. Since hepatocytes are the primary source
of AMBP-1 biosynthesis in the liver, a co-culture strategy
using hepatocyte and Kupffer cells were employed to
determine whether LPS directly or by increasing pro-
inflammatory cytokines from Kupffer cells downregulates
AMBP-1 production. Hepatocytes and Kupffer cells were
isolated from normal Sprague–Dawley rats and cells were co-
cultured and treated with LPS for 24 h. Protein extracts were
subjected to Western analysis using anti-AMBP-1 antibody
and anti-β-actin antibody was used as loading control.
Treatment with 1.0, 10 and 100 ng/ml LPS in a co-culture of
hepatocytes and Kupffer cells produced 35%, 40% and 50%
inhibition of AMBP-1 protein expression, respectively (Fig. 1).
A representative Western blot is shown in Fig. 1A. Please note,
β-actin levels were relatively similar among different experi-
mental groups. The calculated ratios between AMBP-1 and
actin protein expression (AMBP-1/β-actin) from a number of
experiments are shown in Fig. 1B. Since AMBP-1 is basically
a secretory protein, we collected culture supernatants from the
co-culture experiments after LPS treatment and AMBP-1
protein secretions were measured. LPS treatment at both 10
and 100 ng/ml produced 27% and 46% decrease of AMBP-1
proteins compared to untreated controls, respectively. How-
ever, no statistical differences between control and treatment
groups were found (Fig. 2). This suggests that the decrease in
the protein levels in cell lysates of co-culture samples reflects a
Fig. 2. LPS treatment produced no increase in AMBP-1 secretion in a co-culture
of hepatocytes and Kupffer cells. (A) Cell supernatants from co-culture
experiments treated with LPS were concentrated 10 fold with Centricon-50 and
a 2-μl aliquot was analyzed by Western blot under non-reducing conditions
using anti-AMBP-1 antibody. (B) Arbitrary densitometric values obtained from
the blot are shown. Data are presented as mean±SE (n=3).
Fig. 1. LPS treatment downregulates AMBP-1 in a co-culture of hepatocytes and
Kupffer cells. (A) Cells in co-culture for 4 h were treated with LPS (1.0, 10 and
100 ng/ml). 24 h post treatment, cells were lysed in HEPES buffer containing
protease inhibitors and protein levels were measured. Equal amounts of protein
(25 μg) were electrophoresed on 3–8% NuPAGE Tris-Acetate gels under non-
reducing conditions and Western blotted with anti-human complement factor H
antibody (AMBP-1). Duplicate aliquots of protein (25 μg) were electrophoresed
on 4–12%NuPAGEBis-Tris gels under reducing conditions andWestern blotted
with anti-β-actin antibody (β-actin). (B) The ratios between AMBP-1 and β-
actin protein expressions (calculated as arbitrary densitometric values obtained
from AMBP-1 protein expression divided by β-actin values in corresponding
lanes) are shown. Data are presented as mean±SE (n=6) and compared by one-
way ANOVA and Student–Newman–Keuls method. *Pb0.05 versus control.
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secretion. To further demonstrate the cross-feeding between
these two cell types, hepatocytes and Kupffer cells were plated
in transwell chambers separated by a 0.4-μm membrane,
treated with LPS and cell lysates were examined for AMBP-1
protein expression. The transwell chamber with the 0.4-μm
membrane allows free exchange of molecules such as proteins
and cytokines while preventing direct contact between the two
cell populations. LPS treatment at both 10 and 100 ng/ml
exhibited 29% and 38%, decrease in AMBP-1 protein
expression compared to control samples, respectively (Fig.
3). These results are similar to what was observed in the co-
culture experiments (Fig. 1). To determine whether LPS
directly inhibits AMBP-1, hepatocytes were treated with LPS
for 24 h and AMBP-1 expression was examined. The results
showed that LPS treatment had no significant effect in AMBP-
1 levels in cultured hepatocytes alone (Fig. 4). To rule out the
possibility that the LPS effects on AMBP-1 levels in co-culture
were due to the downregulation of AMBP-1 levels in Kupffer
cells, cultured Kupffer cells were treated with LPS for 24 h and
AMBP-1 expression was examined. AMBP-1 levels were
extremely low in Kupffer cell culture and LPS had no further
effect over the control levels (Fig. 5). These data suggest that
the downregulation of AMBP-1 in LPS treated co-culture
could be due to the increase of pro-inflammatory cytokines
from Kupffer cells.Fig. 3. LPS treatment attenuates AMBP-1 expression in culture of hepatocytes
and Kupffer cells separated by the use of 0.4 μm transwell inserts. (A) Equal
amount of proteins (25 μg) from cell lysates were run on 3–8% NuPAGE gels
under non-reducing conditions and Western blotted using anti-AMBP-1
antibody. Duplicate aliquots of protein (25 μg) were electrophoresed on
4–12% NuPAGE Bis-Tris gels under reducing conditions and Western
blotted with anti-β-actin antibody (β-actin). (B) The ratios between AMBP-1
and β-actin protein expressions are shown. Data are presented as mean±SE
(n=5) and compared by one-way ANOVA and Student–Newman–Keuls
method. *Pb0.05 versus control.
Fig. 5. AMBP-1 protein expression is extremely low in Kupffer cells and LPS
had no further effect on its expression. (A) Kupffer cells in culture for 24 h were
treated with LPS (1.0, 10 and 100 ng/ml) and incubated for 24 h at 37 °C. Cells
were lysed and equal amount of proteins (15 μg) were electrophoresed and
Western blotted with either AMBP-1 or anti-β-actin antibody. (B) The ratios
between AMBP-1 and β-actin are shown. Data are presented as mean±SE
(n=6) and compared by ANOVA and Student–Newman–Keuls method.
Fig. 4. LPS treatment has no direct effect on AMBP-1 expression in hepatocytes.
(A) Hepatocytes in culture for 4 h were treated with LPS (1.0, 10 and 100 ng/ml)
and incubated for 24 h at 37 °C. Cells were lysed and equal amount of proteins
(25 μg) were electrophoresed and Western blotted with either AMBP-1 or anti-β-
actin antibody as described in the legend to Fig. 1. (B) The ratios between AMBP-
1 and β-actin protein expression are shown. Data are presented as mean±SE
(n=6) and compared by ANOVA and Student–Newman–Keuls method.
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Hepatocytes after IL-1β or TNF-α treatment
To test whether the observed downregulation of AMBP-1 in
LPS treated co-culture was related to an increase in cytokine
release, TNF-α and IL-1β levels in the co-culture cell
supernatant were measured. LPS treatment at 100 ng/ml
produced a significant increase in both TNF-α levels compared
to untreated samples. In the case of IL-1β, hepatocytes alone
produced a significant increase in IL-1β in the presence of
100 ng/ml LPS. These levels were not further increased in LPS
treated co-culture [21]. To confirm that IL-1β and TNF-α
indeed downregulate hepatocyte expression of AMBP-1
protein, hepatocytes were treated with either IL-1β or TNF-α
for 24 h. The cell lysates were subjected to Western blotting and
examined for AMBP-1 protein expression. Treatment with IL-
1β at 1.0 and 10 ng/ml produced 53 and 61% inhibition of
AMBP-1 protein levels, respectively (Fig. 6). Similarly, TNF-α
at 1.0 and 10 ng/ml exhibited 53 and 50% inhibition of AMBP-
1 protein levels, respectively (Fig. 6). No significant differences
were observed in β-actin expression among different treatment
groups and control.
4. Discussion
AMBP-1, identical to complement factor H, specifically
binds AM and regulates AM's bioactivities [13–15]. AMBP-1 is
a 120-kDa molecular weight protein composed of 20 repetitivedomains of short consensus repeats with approximately 60
amino acids in length. The main function of complement factor
H known so far is to act as a cofactor of complement factor I for
C3b cleaving and promotes the dissociation of C3bBb complex
[22,23]. Structure–functional analysis studies mapped two
binding sites for AM in the complement factor H molecule
which were distinct from the C3b binding sites [24]. The binding
between AM and complement factor H has important physio-
logical consequences. The presence of a binding protein can alter
the biological function of a potent factor and determines its
inhibitory or stimulatory capabilities. A recent study suggested
that AM is degraded by metalloproteinase-2 and that the
protein–protein binding interaction of AM with AMBP-1
prevents this degradation [25]. However, the mechanism of
action is still unknown. In light of this report, it is plausible that
AMBP-1 exerts its effects on AM by preventing the cleavage of
AM by metalloproteinases. Recently we have shown that in a rat
model of sepsis or endotoxemia, AMBP-1 gene and protein
expression of hepatic tissue was significantly downregulated in
the late phase of sepsis [19]. Even though AM is upregulated
during sepsis primarily due to elevated levels of LPS [26], the
vascular response to AM is significantly reduced in late sepsis
[12]. This reduction in vascular response is attributed to the
decrease in AMBP-1 levels. Thus, the hypodynamic response
generally observed in late sepsis characterized by reduced
vascular response to AM is presumably due to the decrease in
AMBP-1 levels.
We have previously shown that administration of AM/
AMBP-1 maintains cardiovascular response, decreases pro-
inflammatory cytokine levels and reduces mortality in a rat
Fig. 6. AMBP-1 protein expression in hepatocytes is significantly attenuated by IL-1β or TNF-α treatment. (A) Hepatocytes in culture for 4 h were treated with IL-1β
or TNF-α at 1.0 and 10 ng/ml and incubated for 24 h at 37 °C. Cells were lysed and equal amount of proteins (25 μg) were electrophoresed and Western blotted with
either AMBP-1 or anti-β-actin antibody. (B) The ratios between AMBP-1 and β-actin protein expression are shown. Data are presented as mean±SE (n=6) and
compared by ANOVA and Student–Newman–Keuls method. *Pb0.05 versus control.
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suppressed LPS-induced TNF-α expression and release from
Kupffer cells [20]. We have also shown that AMBP-1 is
downregulated in the late phase of sepsis and LPS plays a
critical role in the reduction of AMBP-1 [19]. In this study, we
demonstrated that the downregulation of AMBP-1 in late
sepsis or endotoxemia is due to the release of increased levels
of pro-inflammatory cytokines from Kupffer cells rather than a
direct effect of LPS. Our conclusion is based on the fact that
[1] LPS treatment in a co-culture of hepatocytes and Kupffer
cells significantly attenuated AMBP-1 protein expression, [2]
no increase of AMBP-1 protein secretion was observed with
LPS treatment in co-culture, [3] LPS treatment in transwell
cultures of hepatocytes and Kupffer cells significantly down-
regulated AMBP-1 protein expression, [4] LPS at concentra-
tions up to 100 ng/ml had no significant effect on AMBP-1
expression in cultured hepatocytes, [5] AMBP-1 expression is
extremely low in Kupffer cells and LPS treatment did not
show any further increase from the control levels. Thus, it was
conceivable that LPS had no direct effect on AMBP-1
biosynthesis in the hepatocytes.
Our results with LPS treatment in rat hepatocytes is in good
agreement with previous report that LPS at 1.0 and 10 ng/ml did
not affect AMBP-1 protein expression [27]. A recent report
using quantitative PCR suggests that hepatocytes contain
mRNA for CD14 and TLR-4, the two receptors involved in
LPS regulation, and that LPS at 100 μg/ml significantly
upregulated the CD14 mRNA levels but not the TLR-4 levels
[28]. However, our experiments were conducted with markedly
lower concentrations of LPS (1–100 ng/ml) and that there were
no significant changes in AMBP-1 levels in LPS treatedhepatocyte cultures. Therefore, it is possible that the upregula-
tion of CD14 expression and subsequent signaling via the CD14/
TLR-4 receptors in hepatocytes occurs only at high concentra-
tions of LPS. However, further investigation is warranted for
such a conclusion.
In our study, constitutive level of AMBP-1 protein expres-
sion in Kupffer cells was at least ten fold lower than that seen in
rat hepatocytes and no significant increase was evident with
LPS treatment. However, it was reported using RT-PCR
analysis, complement factor H mRNA was increased up to
eight fold in LPS treated Kupffer cells [27]. Whether this
increase in mRNA levels corresponds to an increase in secreted
protein was not ascertained from that study. Our data clearly
indicated that the source of complement factor H in the liver is
the hepatocytes and that LPS up to 100 ng/ml concentrations,
which will be specific for receptor–ligand interaction, had no
direct effect on either the hepatocyte or Kupffer cell derived
AMBP-1 production.
We have previously shown that co-culture with hepatocytes
and Kupffer cells treated with 100 ng/ml LPS produced a 5-
fold increase in TNF-α levels compared to untreated controls
[21]. In addition, Hoebe et al. [29] and Scott et al. [30]
demonstrated that LPS treatment caused a significant increase
in TNF-α and IL-6 release from co-culture of hepatocytes and
Kupffer cells. Therefore, we hypothesized that the release of
pro-inflammatory cytokines from Kupffer cells are responsible
for the downregulation of AMBP-1 in LPS induced co-culture.
To test this, we treated cultured hepatocytes with either TNF-α
or IL-1β and examined AMBP-1 protein expression. Our
results clearly indicated that both cytokines significantly
downregulated AMBP-1 protein expression. Our study is in
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secretion of cultured human umbilical vein endothelial cells
[31–33]. It has been reported that interferon-γ also regulates
AMBP-1 in primary hepatocytes [34]. Though our data clearly
indicated that TNF-α and IL-1β significantly downregulated
AMBP-1 protein expression, other pro-inflammatory cytokines
such as IL-6 and interferon-γ could also regulate AMBP-1
expression in hepatocytes. Further studies are warranted to
examine the role of either cytokine in AMBP-1 production in
the co-culture system.
How do pro-inflammatory cytokines downregulate AMBP-1
protein expression? Cytokines are produced in response to
cellular stress such as heat shock, ultraviolet light or adherence
to a foreign surface. These stimuli often activate the mitogen
activated protein kinases which phosphorylate transcription
factors for gene expression. Infection and inflammation also use
the same pathway for initiating cytokine gene expression. Most
of the biological effects of IL-1β take place in cells following
nuclear translocation of NFκB and AP-1, two known factors
common to the IL-1β induced genes. Although the receptors for
TNF-α and IL-1β are clearly different, the post receptor events
could be similar. Unlike the IL-1β receptor, the TNF-α receptor
contains “death domain” that recruits intracellular molecules
involved in initiating programmed cell death or apoptosis. The
pro-inflammatory cytokines such as TNF-α and IL-1β appears
to trigger several events at the same time resulting in
inflammation, tissue destruction and loss of function of the
normal cellular activities [35]. It is plausible that these cytokines
per se has no direct effect on the biosynthesis of AMBP-1 but
rather they cause ultimate shut down of the cellular machinery.
In that regard, it is highly unlikely that the cytokines caused
necrosis of the hepatocytes within the 24-h period studied due to
the fact that we were able to detect similar levels of β-actin
expression in cells treated and untreated with LPS. Our
experiments did not address the role of apoptosis of hepatocytes
in downregulation of AMBP-1. Therefore, further studies are
needed to determine the mechanism by which pro-inflammatory
cytokines downregulate AMBP-1.
Another possibility is proteolytic degradation of protein in
general due to endotoxemia or sepsis. Since AMBP-1 is known
to have a long half life, it is unlikely that specific degradation
plays any role in LPS regulated AMBP-1 expression in
hepatocytes. Future experiments using protease blockers could
provide insights into this notion.
In summary, previously we have demonstrated that LPS
administration downregulated AMBP-1 production in the liver.
The present study was conducted to determine whether LPS
directly or by increasing pro-inflammatory cytokines from
Kupffer cells downregulate AMBP-1 biosynthesis. Our current
data showed that pro-inflammatory cytokines, IL-1β and TNF-
α released from Kupffer cells during sepsis are responsible for
downregulation of AMBP-1.
Acknowledgments
This investigation was supported by NIH grants,
R01GM057468 and R01HL076179 (P. Wang). The authorsthank Mr. Weifeng Dong and Dr. Youxin Ji for their excellent
technical assistances.
References
[1] A.E. Baue, Sepsis research: what did we do wrong? What would
Semmelweis do today? Shock 16 (2001) 1–8.
[2] J. Cohen, G. Guyatt, G.R. Bernard, T. Calandra, D. Cook, D. Elbourne, J.
Marshall, A. Nunn, S. Opal, New strategies for clinical trials in patients
with sepsis and septic shock, Crit. Care Med. 29 (2001) 880–886.
[3] G.R. Bernard, J.L. Vincent, P.F. Laterre, S.P. LaRosa, J.F. Dhainaut, A.
Lopez-Rodriguez, J.S. Steingrub, G.E. Garber, J.D. Helterbrand, E.W. Ely,
C.J. Fisher Jr., Efficacy and safety of recombinant human activated protein
C for severe sepsis, N. Engl. J. Med. 344 (2001) 699–709.
[4] I.H. Chaudry, K.A. Wichterman, A.E. Baue, Effect of sepsis on tissue
adenine nucleotide levels, Surgery 85 (1979) 205–211.
[5] P. Wang, I.H. Chaudry, Mechanism of hepatocellular dysfunction during
hyperdynamic sepsis, Am. J. Physiol. 270 (1996) R927–R938.
[6] W. Ertel, M.H. Morrison, P. Wang, Z.F. Ba, A. Ayala, I.H. Chaudry, The
complex pattern of cytokines in sepsis. Association between prostaglan-
dins, cachectin, and interleukins, Ann. Surg. 214 (1991) 141–148.
[7] A. Waage, A. Halstensen, T. Espevik, Association between tumour
necrosis factor in serum and fatal outcome in patients with meningococcal
disease, Lancet 1 (1987) 355–357.
[8] J.M. Debets, R. Kampmeijer, M.P. van der Linden, W.A. Buurman, C.J.
van der Linden, Plasma tumor necrosis factor and mortality in critically ill
septic patients, Crit. Care Med. 17 (1989) 489–494.
[9] P. Wang, Z.F. Ba, W.G. Cioffi, K.I. Bland, I.H. Chaudry, The pivotal role of
adrenomedullin in producing hyperdynamic circulation during the early
stage of sepsis, Arch. Surg. 133 (1998) 1298–1304.
[10] D.J. Koo, I.H. Chaudry, P. Wang, Mechanism of hepatocellular
dysfunction during sepsis: the role of gut-derived norepinephrine (review),
Int. J. Mol. Med. 5 (2000) 457–465.
[11] P. Wang, Adrenomedullin in sepsis and septic shock, Shock 10 (1998)
383–384.
[12] M. Zhou, Z.F. Ba, I.H. Chaudry, P. Wang, Adrenomedullin binding
protein-1 modulates vascular responsiveness to adrenomedullin in late
sepsis, Am. J. Physiol., Regul. Integr. Comp. Physiol. 283 (2002)
R553–R560.
[13] T.H. Elsasser, S. Kahl, A. Martinez, L.M. Montuenga, R. Pio, F. Cuttitta,
Adrenomedullin binding protein in the plasma of multiple species:
characterization by radioligand blotting, Endocrinology 140 (1999)
4908–4911.
[14] R. Pio, T.H. Elsasser, A. Martinez, F. Cuttitta, Identification,
characterization, and physiological actions of factor H as an adrenome-
dullin binding protein present in human plasma, Microsc. Res. Tech. 57
(2002) 23–27.
[15] R. Pio, A. Martinez, E.J. Unsworth, J.A. Kowalak, J.A. Bengoechea, P.F.
Zipfel, T.H. Elsasser, F. Cuttitta, Complement factor H is a serum-binding
protein for adrenomedullin, and the resulting complex modulates the
bioactivities of both partners, J. Biol. Chem. 276 (2001) 12292–12300.
[16] S. Yang, M. Zhou, I.H. Chaudry, P. Wang, Novel approach to prevent the
transition from the hyperdynamic phase to the hypodynamic phase of
sepsis: role of adrenomedullin and adrenomedullin binding protein-1, Ann.
Surg. 236 (2002) 625–633.
[17] D.E. Fowler, S. Yang, M. Zhou, I.H. Chaudry, H.H. Simms, P. Wang,
Adrenomedullin and adrenomedullin binding protein-1: their role in the
septic response, J. Surg. Res. 109 (2003) 175–181.
[18] P.F. Zipfel, C. Skerka, Complement factor H and related proteins: an
expanding family of complement-regulatory proteins? Immunol. Today 15
(1994) 121–126.
[19] Y. Cui, Y. Ji, R. Wu, M. Zhou, P. Wang, Adrenomedullin binding protein-1
is downregulated during polymicrobial sepsis in the rat, Int. J. Mol. Med.
17 (2006) 925–929.
[20] R. Wu, M. Zhou, P. Wang, Adrenomedullin and adrenomedullin binding
protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer
cells, Regul. Pept. 112 (2003) 19–26.
772 A. Jacob et al. / Biochimica et Biophysica Acta 1772 (2007) 766–772[21] R. Wu, X. Cui, W. Dong, M. Zhou, H.H. Simms, P. Wang, Suppression of
hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the
central role of proinflammatory cytokines, Int. J. Mol. Med. 18 (2006)
339–346.
[22] S. Kuhn, C. Skerka, P.F. Zipfel, Mapping of the complement regulatory
domains in the human factor H-like protein 1 and in factor H1, J. Immunol.
155 (1995) 5663–5670.
[23] S. Kuhn, P.F. Zipfel, Mapping of the domains required for decay
acceleration activity of the human factor H-like protein 1 and factor H, Eur.
J. Immunol. 26 (1996) 2383–2387.
[24] A. Martinez, R. Pio, P.F. Zipfel, F. Cuttitta, Mapping of the adrenome-
dullin-binding domains in human complement factor H, Hypertens Res. 26
(2003) S55–S59 (Suppl).
[25] A. Martinez, H.R. Oh, E.J. Unsworth, C. Bregonzio, J.M. Saavedra, W.G.
Stetler-Stevenson, F. Cuttitta, Matrix metalloproteinase-2 cleavage of
adrenomedullin produces a vasoconstrictor out of a vasodilator, Biochem.
J. 383 (2004) 413–418.
[26] S. Yang, M. Zhou, I.H. Chaudry, P. Wang, The role of lipopolysaccharide
in stimulating adrenomedullin production during polymicrobial sepsis,
Biochim. Biophys. Acta 1537 (2001) 167–174.
[27] G. Schlaf, T. Demberg, N. Beisel, H.L. Schieferdecker, O. Gotze, Ex-
pression and regulation of complement factors H and I in rat and human
cells: some critical notes, Mol. Immunol. 38 (2001) 231–239.
[28] T. Hayashi, M. Kishiwada, K. Fujii, H. Yuasa, J. Nishioka, M. Ido, E.C.
Gabazza, K. Suzuki, Lipopolysaccharide-induced decreased protein S
expression in liver cells is mediated by MEK/ERK signaling andNFkappaB activation: involvement of membrane-bound CD14 and toll-
like receptor-4, J. Thromb. Haemost. 4 (2006) 1763–1773.
[29] K.H. Hoebe, R.F. Witkamp, J. Fink-Gremmels, A.S. Van Miert, M.
Monshouwer, Direct cell-to-cell contact between Kupffer cells and
hepatocytes augments endotoxin-induced hepatic injury, Am. J. Physiol.,
Gastrointest. Liver Physiol. 280 (2001) G720–G728.
[30] M.J. Scott, S. Liu, G.L. Su, Y. Vodovotz, T.R. Billiar, Hepatocytes enhance
effects of lipopolysaccharide on liver nonparenchymal cells through close
cell interactions, Shock 23 (2005) 453–458.
[31] H. Dauchel, N. Julen, C. Lemercier, M. Daveau, D. Ozanne, M. Fontaine,
J. Ripoche, Expression of complement alternative pathway proteins by
endothelial cells. Differential regulation by interleukin 1 and glucocorti-
coids, Eur. J. Immunol. 20 (1990) 1669–1675.
[32] R.A. Brooimans, A.A. van der Ark, W.A. Buurman, L.A. van Es, M.R.
Daha, Differential regulation of complement factor H and C3 production in
human umbilical vein endothelial cells by IFN-gamma and IL-1,
J. Immunol. 144 (1990) 3835–3840.
[33] M. Coulpier, S. Andreev, C. Lemercier, H. Dauchel, O. Lees, M. Fontaine,
J. Ripoche, Activation of the endothelium by IL-1 alpha and glucocorti-
coids results in major increase of complement C3 and factor B production
and generation of C3a, Clin. Exp. Immunol. 101 (1995) 142–149.
[34] G. Schlaf, N. Beisel, B. Pollok-Kopp, H. Schieferdecker, T. Demberg, O.
Gotze, Constitutive expression and regulation of rat complement factor H
in primary cultures of hepatocytes, Kupffer cells, and two hepatoma cell
lines, Lab. Invest. 82 (2002) 183–192.
[35] C.A. Dinarello, Proinflammatory cytokines, Chest 118 (2000) 503–508.
